性腺功能低下是老年男性骨质疏松发生的重要危险因素,而前列腺癌剥夺雄激素治疗中的骨丢失却很少有人测定。作者对26例开始接受激素治疗的前列腺癌患者在睾丸切除或药物去势前及此后每6个月测定股骨颈的骨密度,并随访6至42个月。另对16例去势后3至8年的患者以同样的时间间隔测 Hypogonadism is an important risk factor for osteoporosis in older men, and bone loss in androgen-deprived prostate cancer is rarely measured. The authors measured the bone mineral density of the femoral neck in 26 patients with hormone-treated prostate cancer before orchiectomy or every 6 months thereafter and were followed up for 6 to 42 months. The other 16 cases of castration after 3 to 8 years of patients measured at the same time interval